These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29439912)

  • 21. Optimal dosing of rivaroxaban is undefined.
    Moore TJ
    BMJ; 2016 Oct; 355():i5549. PubMed ID: 27756735
    [No Abstract]   [Full Text] [Related]  

  • 22. Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial).
    Balla SR; Cyr DD; Lokhnygina Y; Becker RC; Berkowitz SD; Breithardt G; Fox KAA; Hacke W; Halperin JL; Hankey GJ; Mahaffey KW; Nessel CC; Piccini JP; Singer DE; Patel MR
    Am J Cardiol; 2017 Jun; 119(12):1989-1996. PubMed ID: 28477860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivaroxaban-induced hemorrhagic pericardial tamponade in end-stage renal disease.
    Rapista N; Sarkar S; Chaudhary R
    J Thromb Thrombolysis; 2020 Nov; 50(4):982-983. PubMed ID: 32495012
    [No Abstract]   [Full Text] [Related]  

  • 24. Optimizing the Safe Use of Direct Oral Anticoagulants in Older Patients: A Teachable Moment.
    Sennesael AL; Dogné JM; Spinewine A
    JAMA Intern Med; 2015 Oct; 175(10):1608-9. PubMed ID: 26237648
    [No Abstract]   [Full Text] [Related]  

  • 25. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Yao X; Abraham NS; Sangaralingham LR; Bellolio MF; McBane RD; Shah ND; Noseworthy PA
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration.
    Borne RT; O'Donnell C; Turakhia MP; Varosy PD; Jackevicius CA; Marzec LN; Masoudi FA; Hess PL; Maddox TM; Ho PM
    BMC Cardiovasc Disord; 2017 Sep; 17(1):236. PubMed ID: 28865440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which oral anticoagulant for atrial fibrillation.
    Med Lett Drugs Ther; 2016 Apr; 58(1492):45-6. PubMed ID: 27049507
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation.
    Tamayo SG; Simeone JC; Nordstrom BL; Patel MR; Yuan Z; Sicignano NM; Peacock WF
    J Am Coll Cardiol; 2016 Sep; 68(10):1144-6. PubMed ID: 27585515
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of rivaroxaban in atrial fibrillation and acute coronary syndromes.
    Reddy P; Giugliano RP
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):526-32. PubMed ID: 24659084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serpentine-like right atrial mass and fulminant bilateral pulmonary embolism during treatment with rivaroxaban.
    Mayr A; Klug G; Greulich S; Metzler B; Feuchtner G
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):1001-2. PubMed ID: 26939567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
    Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rivaroxaban Precision Dosing Strategy for Real-World Atrial Fibrillation Patients.
    Konicki R; Weiner D; Herbert Patterson J; Gonzalez D; Kashuba A; Cao YC; Gehi AK; Watkins P; Powell JR
    Clin Transl Sci; 2020 Jul; 13(4):777-784. PubMed ID: 32267996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal Function Considerations for Stroke Prevention in Atrial Fibrillation.
    Fanikos J; Burnett AE; Mahan CE; Dobesh PP
    Am J Med; 2017 Sep; 130(9):1015-1023. PubMed ID: 28502818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute tubulo-interstitial nephritis due to RIVAROXABAN (XARELTO)].
    Dantec A; Virot JS; Filancia A; Angonin R; Nefti H
    Presse Med; 2017 May; 46(5):541-542. PubMed ID: 28483286
    [No Abstract]   [Full Text] [Related]  

  • 35. Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation: A Prospective Magnetic Resonance Imaging Study.
    Gioia LC; Kate M; Sivakumar L; Hussain D; Kalashyan H; Buck B; Bussiere M; Jeerakathil T; Shuaib A; Emery D; Butcher K
    Stroke; 2016 Jul; 47(7):1917-9. PubMed ID: 27222524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rivaroxaban in high-risk patients].
    Špinar J; Špinarová L
    Vnitr Lek; 2017; 63(6):424-430. PubMed ID: 28840739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemorrhagic Complications of Rivaroxaban After Eyelid Surgery.
    Liu CY; Samimi DB; Tao JP
    Ophthalmic Plast Reconstr Surg; 2016; 32(1):74. PubMed ID: 26735965
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Halperin JL; Hankey GJ; Wojdyla DM; Piccini JP; Lokhnygina Y; Patel MR; Breithardt G; Singer DE; Becker RC; Hacke W; Paolini JF; Nessel CC; Mahaffey KW; Califf RM; Fox KA;
    Circulation; 2014 Jul; 130(2):138-46. PubMed ID: 24895454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation.
    Hernandez I; Zhang Y; Saba S
    Am J Cardiol; 2017 Nov; 120(10):1813-1819. PubMed ID: 28864318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban.
    Tsyganov A; Shapieva A; Sandrikov V; Fedulova S; Mironovich S; Dzeranova A; Lyan E
    BMC Cardiovasc Disord; 2017 Jun; 17(1):171. PubMed ID: 28662693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.